Drug Search Results
More Filters [+]

Diethylstilbestrol

Alternative Names: diethylstilbestrol, stilbetin, stilphostrol, stilbestrol
Latest Update: 2013-06-26
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: HPG Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Bangladesh | Canada | Chile | France | Greece | India | Ireland | Malta | New Zealand | Peru | Russia | Taiwan | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Diethylstilbestrol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title